Scientists discover rare genetic condition that attacks kids’ immune systems
Next-generation Sequencing In Ocular Oncology Brings Advances In Diagnosis, Management
Today's technology proves faster, better, cheaper.
(Image Credit: AdobeStock/Cavan)
Reviewed by J. William Harbour, MD
Next-generation sequencing (NGS), or massively parallel sequencing, is a recent advancement in DNA technology that allows for the analysis of genetic material much more quickly and at a lower cost than previously possible. Traditionally, analyzing genetic material required creating physical maps, performing single-gene sequencing, or using gene panels.
J. William Harbour, MD, an ocular oncology specialist, discussed how modern genetics advances the understanding of ocular cancer onset and progression during the Masonic Charity Foundation of Oklahoma Distinguished Lecture Series at the Dean McGee Eye Institute in Oklahoma City, Oklahoma. Harbour is a professor and holds the David Bruton Jr Chair in Ophthalmology at UT Southwestern Medical Center in Dallas, Texas.
Before NGS, DNA strands were sequenced from beginning to end in a time-intensive, laborious process. In a significant technological advance, NGS fragments the DNA into many pieces, sequences them individually, and then reassembles the desired section all at once.
NGS and retinoblastomaRetinoblastoma, a childhood ocular cancer, has 2 forms: nonhereditary and hereditary. The nonhereditary form is unilateral, carries no increased risk of secondary cancers, and has a later onset. In contrast, the hereditary form is multifocal, bilateral, transmitted through autosomal dominant inheritance, carries an increased risk of secondary cancers, and manifests earlier.1 Harbour emphasized that differentiating between these 2 forms in high-risk children is now possible overnight, compared to the months required before NGS.
A recent study2 recommended dedicated ophthalmic screening for all children at risk for retinoblastoma above the general population's risk. The frequency of examinations is adjusted based on the expected risk for the RB1 mutation. Genetic counseling and testing clarify retinoblastoma risk in children with a family history. Examination schedules are stratified for high-, intermediate-, and low-risk children, with high-risk children requiring more frequent screenings, often under anesthesia.
An "at-risk" patient is defined by the expert panel as an individual with a family history of retinoblastoma in a parent, sibling, or a first- or second-degree relative. The ability to rapidly identify children at higher risk for retinoblastoma at an early age enhances the management of this population.
Sequencing to identify RB1, the retinoblastoma gene, using traditional methods costs at least $4000 (~$8000 in 2024 dollars) and is typically not covered by insurance; however, NGS is more affordable and often covered by insurance.
NGS potentialThe utility of NGS extends beyond identifying retinoblastoma, encompassing numerous eye diseases—both malignant and benign—and systemic cancers. Some systemic diseases characterized by ocular tumors include tuberous sclerosis, von Hippel-Lindau disease, and neurofibromatosis types 1 and 2. According to Harbour, genetic testing can now be performed rapidly and cost-effectively to diagnose these conditions accurately.
"In a patient with an ocular tumor, the clinician may be uncertain if it is retinoblastoma or tuberous sclerosis," he said. "There are numerous ocular cancers, and having specific genetic information available is helpful without the need for a biopsy. A blood test or cheek swab may provide the information."
Harbour described the case3 of a boy aged 12 years with bilateral retinal tumors and no family history. The differential diagnosis included retinal astrocytic hamartoma, retinoblastoma, and retinocytoma. Multimodal imaging and genetic testing confirmed bilateral retinocytoma. Germline genetic testing showed no mutations in the tuberous sclerosis complex subunit (TSC1 or TSC2) genes but identified a novel mutation in RB1, confirming bilateral retinocytoma in a patient with germline RB1 mutation.
Genetic information from NGS is crucial for patient and family counseling. It informs families about inheritance patterns and the potential for passing the gene to offspring. This knowledge can streamline treatment choices.
Finally, genetic testing provides prognostic insights. Harbour noted that a BAP1 mutation, for instance, indicates a poor prognosis in ocular melanoma, prompting consideration for clinical trial enrollment or close systemic metastasis monitoring.4 In contrast, an EIF1AX mutation suggests a favorable prognosis.5 "We are entering an exciting era of science and technology where the power of genetics can be harnessed to improve diagnosis, treatment, and quality of life for many more patients," Harbour concluded.
J. William Harbour, MD E: William.Harbour@UTSouthwestern.Edu Harbour is a professor, the David Bruton Jr Chair in Ophthalmology, and CPRIT Established Investigator in Cancer Research, UT Southwestern Medical Center, Dallas, Texas. He has a financial interest in the gene expression profiling related to BAP1. References:Clinical Expertise
Biochemical Genetics/Inherited Disorders of MetabolismThe Biochemical Genetics Clinic consists of a multidisciplinary team dedicated to providing family-focused care to children and adults who have been diagnosed with an Inherited Disorder of Metabolism. It provides both inpatient and outpatient lifelong follow up for this patient population. This multidisciplinary approach allows us to offer medical, nutritional and educational assistance to individuals and their families.
Cancer GeneticsThe UAB Clinical Cancer Genetics team consists of specially trained genetic counselors and physicians who can investigate cancer risk in a family and provide clear and clinically relevant information in a supportive environment. This information may be helpful in making medical decisions about how to manage risk for cancer. The initial consultation will involve the following:
Hour-long session focusing on your questions and concerns about cancer risk
Opportunity to learn about cancer in a way you can understand, including:
Risk to you and your close relatives
Available genetic testing options and whether or not testing is appropriate for you and your family members
Legal protections you have against employment or insurance genetic discrimination
Options for insurance coverage or reimbursement for genetic testing
Options for participation in research and registries
Cancer genetic testing is not recommended for everyone. Many factors need to be considered and will be discussed during your genetic consultation. The cost for genetic testing varies and may or may not be covered by insurance.
Learn more
Cleft Lip/Palate ClinicThe UAB Cleft Center is a multidisciplinary clinic includes a plastic surgeon, medical geneticist and a genetic counselor. Other specialties include audiology, speech and language pathology, pediatric otolaryngology and maxillofacial surgery.
Learn more
Genetic CounselingThe UAB Genetic Counseling Clinic provides counseling and risk assessment for a variety of indications including recurrent pregnancy loss, personal and family history of genetic disease, and advanced maternal age. Patients meet with a genetic counselor to discuss risk assessment and testing options.
General GeneticsThe general genetics clinic provides evaluation, counseling, and ongoing management for children and adults with known or suspected genetic disorders. Our goal is to determine the underlying reasons for the problems present in the individual, to communicate this information to the patient or family and to assist with ongoing management of these conditions. This clinic is staffed by physicians, genetic counselors and nurses. We evaluate patients from all over the region for a variety of reasons including developmental delay, birth defects and a family history of genetic disease.
Learn more
Huntington's DiseaseThe UAB Huntington's Clinic is certified as a Huntington's Disease Society of America (HDSA) Center of Excellence. This multidisciplinary clinic provides evaluation, diagnosis, treatment and predictive testing for individuals who are affected by or at risk for Huntington's disease.
Learn more
NeurofibromatosisThe UAB Neurofibromatosis Clinic functions as a multidisciplinary team led by Dr. Bruce Korf, who have extensive experience in caring for patients with this condition. Clinic staff include genetic counselors and nurses, as well as access to specialists as needed. The clinic serves patients and their families dealing with the lifelong medical, psychological and social implications of this diagnosis.
Learn more
Pediatric Cancer GeneticsThe Pediatric Cancer Genetics Clinic at Children's of Alabama provides cancer and genetic risk assessments for children, recommendations for managing cancer risk, as well as education and emotional support for families affected by hereditary cancer syndromes.
We are dedicated to continually working to find missing pieces in the cancer genetics story. We want to help determine whether your children are at risk for or have a hereditary explanation for their cancer, and if so, what can be done to prevent future or address it as soon as possible.
Learn more
PrenatalThe UAB Prenatal Clinic is a multidisciplinary clinic that includes physicians from the UAB Department of OB/GYN Division of Maternal and Fetal Medicine, ultrasound technicians and genetic counselors. Services offered through this clinic include targeted ultrasound, chorionic villus sampling and amniocentesis. Genetic counselors provide patient counseling and risk assessment regarding a variety of indications, including abnormal serum screening, advanced maternal age, drug and medication exposures, and personal and family history of genetic disease.
Learn more
Tuberous SclerosisThis clinic provides service to patients who have an established or suspected diagnosis of tuberous sclerosis complex (TSC). Our interdisciplinary team includes experts from genetics, neurology, dermatology and genetic counseling. In addition, we have ready access to consultants in endocrinology, pulmonology, nephrology, neurosurgery, ophthalmology and more. The goal of this clinic is to provide patients and their families with access to medical providers who are familiar with the healthcare guidelines and medical or emotional concerns of patients with tuberous sclerosis complex. Our providers also strive to have the most current information on treatment and research in the field.
Learn more
Undiagnosed Diseases ProgramThe Undiagnosed Diseases Program (UDP) seeks to meet the needs of patients with severe chronic medical conditions in whom a diagnosis has not been made despite extensive efforts by the referring physician. Achieving an accurate diagnosis can be instrumental in guiding management, treatment and counseling. Our program is
Learn more
Diagnostic Methods For Somatic And Germ Line Mosaicism
Diagnostic methods for somatic and germ line mosaicism
(A) Hypothetical pedigree of Segmental neurofibromitosis type 1, and (below) molecular analysis showing somatic mosaicism. The three-generation pedigree illustrates the occurrence of a sporadic mutation (shown in red) in a second-generation male (represented as squares) manifested as a cafe-au-lait skin lesion that is typical of NFI. Although this disorder is typically inherited as an autosomal-dominant trait, none of the offspring of the affected individual show the abnormality. Moreover, molecular analysis reveals a putative deletion (MUT) in the NF1 gene in DNA obtained from the abnormal skin of the affected patient. By contrast, only wild-type (WT) DNA is noted in the other tissues. The combination of the clinical information and the molecular information supports the diagnosis of a somatic mosaic state in the affected patient. (B) Hypothetical pedigree and molecular analysis showing germ-line mosaicism in tuberous sclerosis. Although this disorder is inherited as an autosomal-dominant trait, the pedigree is more consistent with either autosomal-recessive inheritance or germ-line mosaicism for a mutation in one of the tuberous sclerosis genes in one of the parents. DNA analysis reveals that the father's germ cells, but not other tissues, harbour the mutation (MUT). Due to the inaccessibility of female germ cells, the molecular analysis in such instances frequently remains incomplete.
Could two pieces of a stone mosaic ever be identical? Of course, the answer is no--and each stone's variation subtly contributes value to the finished work. Why should your cells be any different?
Comments
Post a Comment